Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)

Clinical trial NCT00988559 · COMPLETED

Trial details

NCT number: NCT00988559
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HPV16 Positive Cervical Intraepithelial Neoplasia (CIN 2/3)

Start date: 2009-09-01
Primary completion: 2016-07-01
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.